Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

75.7K
Overview
75.7K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

80
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
80
Tissue Transplantation01:24

Tissue Transplantation

594
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
594
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

96
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
96
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

103
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
103

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Worsening Heart Failure.

The Medical clinics of North America·2025
Same author

Tolerability and clinical efficacy of letermovir for primary cytomegalovirus prophylaxis after heart transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2025
Same author

Association of diuretic requirement and right heart failure post-LVAD implantation.

JHLT open·2025
Same author

Early Renal Outcomes Following Heart Transplantation Using Organs Procured After Circulatory Death.

Journal of the American Heart Association·2024
Same author

The Association Between Pulmonary Vascular Resistance and Posttransplant Outcomes Differs by Left Ventricular Assist Device Status.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2024
Same author

The effect of tablet computer-based telemonitoring added to an established telephone disease management program on heart failure hospitalizations: The Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) III Randomized Controlled Trial.

American heart journal·2023

Related Experiment Video

Updated: Oct 16, 2025

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model
06:45

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model

Published on: February 7, 2022

3.6K

Immunosuppression and Heart Transplantation.

Nilay Sutaria1, Lynne Sylvia1, David DeNofrio2

  • 1Cardiovascular Center, Tufts Medical Center, Boston, MA, USA.

Handbook of Experimental Pharmacology
|October 21, 2021
PubMed
Summary

This chapter reviews immunosuppressive strategies for heart transplant recipients since 1967. It details current maintenance, induction, and corticosteroid weaning protocols, enhancing cardiac transplant outcomes.

Keywords:
AzathioprineCalcineurin inhibitorsCancerCardiacCorticosteroidCyclosporineEverolimusHeartImmuneImmunosuppressionInductionMaintenanceMycophenolateOrthotopicPrednisoneRejectionSirolimusSteroidTacrolimusTransplantVasculopathymTOR inhibitors

More Related Videos

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
09:25

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on: May 8, 2020

8.1K
A Modified Method for Heterotopic Mouse Heart Transplantion
11:29

A Modified Method for Heterotopic Mouse Heart Transplantion

Published on: June 23, 2014

12.6K

Related Experiment Videos

Last Updated: Oct 16, 2025

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model
06:45

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model

Published on: February 7, 2022

3.6K
An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
09:25

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on: May 8, 2020

8.1K
A Modified Method for Heterotopic Mouse Heart Transplantion
11:29

A Modified Method for Heterotopic Mouse Heart Transplantion

Published on: June 23, 2014

12.6K

Area of Science:

  • Cardiology
  • Immunology
  • Transplantation Medicine

Background:

  • The first human heart transplant in 1967 marked a milestone, driving significant progress in immunosuppression.
  • Effective immunosuppression is critical for long-term graft survival and patient outcomes in cardiac transplantation.

Purpose of the Study:

  • To provide an in-depth analysis of immunosuppressive agents used in heart transplant recipients.
  • To summarize contemporary evidence on maintenance immunosuppressive regimens.
  • To review the efficacy of induction immunosuppression and corticosteroid weaning strategies.

Main Methods:

  • Literature review and evidence synthesis on immunosuppressive protocols in cardiac transplantation.
  • Analysis of data concerning distinct immunosuppression regimens in specific patient populations.

Main Results:

  • Advancements in immunosuppression have significantly improved heart transplant success rates since 1967.
  • Current protocols involve detailed maintenance regimens, effective induction strategies, and approaches to corticosteroid weaning.
  • Tailored immunosuppression is employed for select patient groups.

Conclusions:

  • Contemporary immunosuppression protocols are crucial for optimizing outcomes in heart transplant recipients.
  • Understanding these protocols aids in managing patients and improving long-term graft function.
  • This review elucidates current best practices in cardiac transplantation immunosuppression.